The outlet NOTUS was the first to break the news, citing an internal email it obtained written by government officials. Agencies under the Department of Health and Human Services have been told to seek alternatives, mainly ChatGPT or Gemini. The shift could throw a wrench in the FDA’s plans to use Claude for speedy drug approvals. 

Researchers: “Clinicians’ perceptions about older patients’ interest in and ability to use mobile health apps may negatively impact recommendation of mHealth apps and subsequent adoption by older adults.”

The technology first gained CE mark approval for the treatment of paroxysmal AFib in 2021, when PFA was still brand new. Now, thanks to positive results from the ADVANTAGE AF clinical trial, it is approved for persistent AFib as well. 

Multiple cardiology societies responded to an HHS request for public feedback by outlining some of the current barriers to wider AI adoption. "It is essential that any policy frameworks must reaffirm that clinicians—not algorithms—remain at the center of patient care," ACC President Christopher Kramer, MD, said. 

Lantheus’ version of a radiopharmaceutical capable of targeting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been tentatively approved by the FDA.

The patient, 78, presented with severe AR and no signs of calcification. She was considered a poor choice for surgery or traditional TAVR due to multiple risks. That is where the new-look ATLAS technique came in.

Typically, these cancers are treated via surgical resection, but ablative techniques have gained recognition in recent years due to their less invasive nature. 

More than 2,000 cardiologists are required to participate in the new payment model. According to CMS, the long-term goal is to track and reduce the high healthcare costs associated with treating heart failure.

RadNet Inc. acquired assets of the Annapolis, Maryland-based physician practice in November for $29 million, the company confirmed March 2. 

For the year, the Raleigh, North Carolina-based imaging group logged consolidated revenues of $1 billion, up 7% compared to $945 million in 2024.